These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 3582746)

  • 1. Factors affecting monoclonal antibody production in culture.
    Reuveny S; Velez D; Macmillan JD; Miller L
    Dev Biol Stand; 1987; 66():169-75. PubMed ID: 3582746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of PER.C6 cells cultivated under fed-batch conditions at low glucose and glutamine levels.
    Maranga L; Goochee CF
    Biotechnol Bioeng; 2006 May; 94(1):139-50. PubMed ID: 16523524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems.
    Kurkela R; Fraune E; Vihko P
    Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of monoclonal antibodies in culture.
    Reuveny S; Velez D; Riske F; MacMillan JD; Miller L
    Dev Biol Stand; 1985; 60():185-97. PubMed ID: 3930316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 2. Effects of serum concentration, dissolved oxygen concentration, and medium pH in a batch reactor.
    Ozturk SS; Palsson BO
    Biotechnol Prog; 1991; 7(6):481-94. PubMed ID: 1367750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody process development using medium concentrates.
    Bibila TA; Ranucci CS; Glazomitsky K; Buckland BC; Aunins JG
    Biotechnol Prog; 1994; 10(1):87-96. PubMed ID: 7764531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glucose on the cultivation of mammalian cells.
    Hu WS; Dodge TC; Frame KK; Himes VB
    Dev Biol Stand; 1987; 66():279-90. PubMed ID: 3582758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-glutamine fed-batch cultures of 293-HEK serum-free suspension cells for adenovirus production.
    Lee YY; Yap MG; Hu WS; Wong KT
    Biotechnol Prog; 2003; 19(2):501-9. PubMed ID: 12675594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of nutritional factors and physical conditions affecting growth and monoclonal antibody production of the hybridoma KB-26.5 cell line.
    Sanfeliu A; Cairo JJ; Casas C; Sola C; Godia F
    Biotechnol Prog; 1996; 12(2):209-16. PubMed ID: 8857191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting cell growth and monoclonal antibody production in stirred reactors.
    Reuveny S; Velez D; Macmillan JD; Miller L
    J Immunol Methods; 1986 Jan; 86(1):53-9. PubMed ID: 3944469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous perfusion culture hybridoma cells for production of monoclonal antibody].
    Mi L; Li L; Feng Q; Yu XL; Chen ZN
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):360-4. PubMed ID: 12192875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
    Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
    Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of metabolism of hybridoma cells cultured in media supplemented with whey or fetal calf serum.
    Legrand C; Capiaumont J; Belleville F; Nabet P
    Biotechnol Prog; 1993; 9(6):573-9. PubMed ID: 7764345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective production of anti-tetanus toxoid and anti-HBsAg human monoclonal antibodies by serum-free culture of hybridomas.
    Kitano K; Ichimori Y; Sawada H; Iwasa S; Sasai S; Tsukamoto K
    Cytotechnology; 1991; 5 Suppl 2():S53-74. PubMed ID: 1367254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
    Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
    Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth, metabolic, and antibody production kinetics of hybridoma cell culture: 1. Analysis of data from controlled batch reactors.
    Ozturk SS; Palsson BO
    Biotechnol Prog; 1991; 7(6):471-80. PubMed ID: 1367749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular pH monitoring as a tool for the study of hybridoma cell behavior in batch and continuous bioreactor cultures.
    Cherlet M; Marc A
    Biotechnol Prog; 1998; 14(4):626-38. PubMed ID: 9694686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.